Compare Royalty Pharma plc Class A Ordinary Shares (RPRX) vs Snap Inc (SNAP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royalty Pharma plc Class A Ordinary Shares vs Snap Inc — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $57.04 (market cap $25.27B), while Snap Inc trades at $6.26 (market cap $9.83B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 2.6× Snap Inc's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Snap Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 0 Days and Snap Inc for 68 Days on average.
| RPRX | SNAP | |
|---|---|---|
Market Cap | $25.27B | $9.83B |
Volume | 3,671,183 | 28,532,342 |
Sector | Health | Media |
52-Week High | $63.96 | $9.09 |
52-Week Low | $35.44 | $3.93 |
Typical Hold Time | 0 Days | 68 Days |
Enterprise Value | $32.50B | $11.39B |
Dividend Yield | 1.66% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Snap Inc. (SNAP) trades at $6.235, up 7.31% on the day, with a bullish technical signal from moving averages but a neutral oscillator stance. Revenue growth is steady, reaching $5.93B in 2025, though the company remains unprofitable with a net income margin of -4.9%. Recent news highlights AI and AR developments, including partnerships with NVIDIA and Salesforce for its SPECS glasses, driving positive sentiment despite regulatory pressures.
The stock presents a speculative opportunity with analyst consensus pointing to a $7.78 price target, but risks include persistent losses, high debt, and intense competition. Upside hinges on monetizing new AI/AR initiatives, while downside protection is limited by weak profitability and macroeconomic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →About Snap Inc
Snap, which refers to itself as a camera company, has one of the most popular social networking apps, Snapchat, in developed regions such as North America and Europe. The firm has approximately 158 million daily active users. Snap generates nearly all of its revenue from advertising with 88% coming from the U.S. The firm is headquartered in Venice, California.
Read more on SNAP →
